Concentrations of alpha- and beta-defensins in gastric juice of patients with various gastroduodenal diseases
- PMID: 15609405
- PMCID: PMC4205393
- DOI: 10.3748/wjg.v11.i1.99
Concentrations of alpha- and beta-defensins in gastric juice of patients with various gastroduodenal diseases
Abstract
Aim: To determine the concentration of alpha- and beta-defensins in gastric juice of patients with various gastroduodenal diseases.
Methods: Concentrations of human neutrophil peptides (HNPs) 1-3, the major forms of alpha-defensins, and human beta-defensin (HBD)-1 and HBD-2 were measured by radioimmunoassay in plasma and gastric juice of 84 subjects, consisting of 54 Helicobacter pylori-infected and 30 uninfected subjects. They included 33 patients with chronic gastritis (CG), 12 with gastric ulcer (GU), 11 with duodenal ulcer (DU), 11 with benign gastric polyp (BGP) and 16 with normal mucosa (N group) on upper endoscopy. Plasma pepsinogen I and II levels, biomarkers for gastric mucosal inflammation and atrophy, were also measured.
Results: Gastric juice HNPs 1-3 levels in patients with CG, GU and BGP were significantly higher than those in patients with DU and N. Gastric juice HBD-2 concentrations in patients with CG and GU were significantly higher than those in the N group, but were significantly lower in DU patients than in GU patients. Gastric juice HBD-1 levels and plasma levels of these peptides were similar in the patient groups. Concentrations of gastric juice HNPs 1-3 and HBD-2 of in H pylori-infected patients were significantly different from those in uninfected subjects. HNPs 1-3 concentrations in gastric juice correlated negatively with plasma pepsinogen I levels and I/II ratios. HBD-2 levels in gastric juice correlated positively and negatively with plasma pepsinogen II concentrations and I/II ratios, respectively.
Conclusion: HNPs 1-3 and HBD-2 levels in gastric juice are diverse among various gastrointestinal diseases, reflecting the inflammatory and atrophic events of the background gastric mucosa affected by H pylori.
Figures


Similar articles
-
High concentrations of human beta-defensin 2 in gastric juice of patients with Helicobacter pylori infection.World J Gastroenterol. 2005 Aug 21;11(31):4782-7. doi: 10.3748/wjg.v11.i31.4782. World J Gastroenterol. 2005. PMID: 16097044 Free PMC article.
-
Elevated concentrations of alpha-defensins in gastric juice of patients with Helicobacter pylori infection.Am J Gastroenterol. 2004 Oct;99(10):1916-23. doi: 10.1111/j.1572-0241.2004.40334.x. Am J Gastroenterol. 2004. PMID: 15447750
-
Circulating ghrelin levels in patients with various upper gastrointestinal diseases.Dig Dis Sci. 2005 May;50(5):833-8. doi: 10.1007/s10620-005-2648-z. Dig Dis Sci. 2005. PMID: 15906753
-
Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection.Korean J Intern Med. 2016 Sep;31(5):835-44. doi: 10.3904/kjim.2016.166. Epub 2016 Sep 1. Korean J Intern Med. 2016. PMID: 27604795 Free PMC article. Review.
-
A Novel View of Human Helicobacter pylori Infections: Interplay between Microbiota and Beta-Defensins.Biomolecules. 2019 Jun 18;9(6):237. doi: 10.3390/biom9060237. Biomolecules. 2019. PMID: 31216758 Free PMC article. Review.
Cited by
-
Gastric antimicrobial peptides fail to eradicate Helicobacter pylori infection due to selective induction and resistance.PLoS One. 2013 Sep 11;8(9):e73867. doi: 10.1371/journal.pone.0073867. eCollection 2013. PLoS One. 2013. PMID: 24040100 Free PMC article.
-
Beta-defensins and analogs in Helicobacter pylori infections: mRNA expression levels, DNA methylation, and antibacterial activity.PLoS One. 2019 Sep 19;14(9):e0222295. doi: 10.1371/journal.pone.0222295. eCollection 2019. PLoS One. 2019. PMID: 31537016 Free PMC article.
-
Cholesterol enhances Helicobacter pylori resistance to antibiotics and LL-37.Antimicrob Agents Chemother. 2011 Jun;55(6):2897-904. doi: 10.1128/AAC.00016-11. Epub 2011 Apr 4. Antimicrob Agents Chemother. 2011. PMID: 21464244 Free PMC article.
-
Selected Markers of Inflammation in the Saliva of Children Infected with Helicobacter pylori.Int J Mol Sci. 2024 Nov 28;25(23):12780. doi: 10.3390/ijms252312780. Int J Mol Sci. 2024. PMID: 39684489 Free PMC article.
-
Gastric alarmin release: A warning signal in the development of gastric mucosal diseases.Front Immunol. 2022 Oct 6;13:1008047. doi: 10.3389/fimmu.2022.1008047. eCollection 2022. Front Immunol. 2022. PMID: 36275647 Free PMC article. Review.
References
-
- van Wetering S, Sterk PJ, Rabe KF, Hiemstra PS. Defensins: key players or bystanders in infection, injury, and repair in the lung? J Allergy Clin Immunol. 1999;104:1131–1138. - PubMed
-
- Chertov O, Yang D, Howard OM, Oppenheim JJ. Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses. Immunol Rev. 2000;177:68–78. - PubMed
-
- Wada A. Studies on biological activity of antimicrobial peptides, defensins, and the inducible mechanism in mammalian cells. Nihon Saikingaku Zasshi. 2003;58:595–602. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous